TOC+Implementation+Guidance+SWG+Meeting+Minutes+3-9-2012

include component="page" wikiName="siframework" page="TOC Header" =ToC Implementation Guidance SWG Meeting Minutes=
 * Date:** 03-09-2012
 * Time:** 3:00 - 4:00pm EDT

Attendance
Tara Garrison, Emma Jones, Russell Leftwich, Meredith Lewis, Holly Miller, Russell Ott, Ashley Swain, David Tao

Action Items

 * **#** ||= **Date Initiated** || **Action** || **Owner** || **Status** ||= **Date Closed** ||
 * 1 ||= 03-09-2012 || Review the Clinical Summaries and provide feedback to Holly || All Volunteers || Open ||= 03-11-2012 ||
 * 2 ||= 03-09-2012 || Reach out to colleagues to get feedback on MU Stage 2 analysis || David Tao || Open ||=  ||

Agenda Items

 * 1) Welcome and Announcements
 * 2) Review David Tao's MU Stage 2 Analysis
 * 3) Review Holly Miller's Clinical Summaries
 * 4) Next Steps

Meeting Minutes

 * MU Stage 2 Analysis**
 * Group reviewed analysis of MU Stage 2 standards completed by David Tao, which is available on the SWG home page.
 * In general, MU Stage 2 aligns to C-CDA, although there are likely a few, undiscovered examples where additional guidance will be needed.
 * Russell mentioned that the NPRM dictates that Advanced Directives are intended to be discrete data, which is one example of this.
 * Another example is reconciled medication list in C-CDA, which is part of MU Stage 2. This was addressed during an HL7 SDWG email exchange yesterday.
 * David has asked others to review the spreadsheet, and although a few have said they would provide feedback, he has not recieved anything yet.
 * Ashley made the request that we cast a wide net to get feedback on the NPRM, to inform the companion guide.
 * David offered to promote the work to the HIE group in an attempt to get feedback; HIE vendors are certainly interested in the analysis.
 * The group agreed that expanding the spreadsheet to included analysis from other sources would be beneficial, and inform the development of the companion guide.


 * Clinical Summaries**
 * David requested that it be expanded to include more information about the information to be exchanged during discharge, for example.
 * Holly asked that David provide the information that he believes is missing before she leaves for vacation on Sunday.
 * Russell agreed to review the document for clinical validity and to reach out to a friend for additional examples to add to the results summaries.
 * The next steps for this work is to put the clinical summaries into "CDA talk." In other words, fill out whatever can be completed in C-CDA.
 * These summaries, when fully complete, will be validated with C-CDA to produce the companion guide.

include component="page" wikiName="siframework" page="space.template.inc_contentleft_end"